Approved
consistent with clarifications described in FDA memo of
1-29-02.
Inventory as of this Action
Requested
Previously Approved
01/31/2005
01/31/2005
2,065
0
0
31,106
0
0
0
0
0
The final rule establishes the
notification and recordkeeping requirements for animal drugs,
biologics, cosmetics, drugs, foods, and medical devices that may
not be marketed or sold in the United States but may be exported
under sections 801(e)(1) and 802 of the Federal Food, Drug, and
Cosmetic Act.
On behalf of this Federal agency, I certify that
the collection of information encompassed by this request complies
with 5 CFR 1320.9 and the related provisions of 5 CFR
1320.8(b)(3).
The following is a summary of the topics, regarding
the proposed collection of information, that the certification
covers:
(i) Why the information is being collected;
(ii) Use of information;
(iii) Burden estimate;
(iv) Nature of response (voluntary, required for a
benefit, or mandatory);
(v) Nature and extent of confidentiality; and
(vi) Need to display currently valid OMB control
number;
If you are unable to certify compliance with any of
these provisions, identify the item by leaving the box unchecked
and explain the reason in the Supporting Statement.